Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
40.68
-1.40 (-3.33%)
At close: Aug 18, 2026, 4:00 PM EDT
41.18
+0.50 (1.23%)
After-hours: Aug 18, 2026, 7:34 PM EDT

Veracyte Revenue

Veracyte had revenue of $150.32M in the quarter ending June 30, 2026, with 15.49% growth. This brings the company's revenue in the last twelve months to $561.90M, up 17.28% year-over-year. In the year 2025, Veracyte had annual revenue of $517.15M with 16.01% growth.

Revenue (ttm)
$561.90M
Revenue Growth
+17.28%
P/S Ratio
5.82
Revenue / Employee
$744,238
Employees
755
Market Cap
3.27B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025517.15M71.38M16.01%
Dec 31, 2024445.76M84.71M23.46%
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019120.37M28.36M30.82%
Dec 31, 201892.01M20.06M27.87%
Dec 31, 201771.95M6.87M10.55%
Dec 31, 201665.09M15.58M31.48%
Dec 31, 201549.50M11.31M29.62%
Dec 31, 201438.19M16.31M74.51%
Dec 31, 201321.88M10.26M88.20%
Dec 31, 201211.63M8.98M339.62%
Dec 31, 20112.65M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RadNet2.27B
Sotera Health Company1.22B
NeoGenomics766.30M
CareDx458.09M
GeneDx Holdings454.43M
Twist Bioscience431.80M
BillionToOne397.41M
Adaptive Biotechnologies308.08M
Revenue Rankings